Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Preclinical development of RAG1-40-31L: a novel small activating RNA-lipid conjugate targeting tumor suppressor gene p21 for treatment of non-muscle invasive bladder cancer
When the marks are larger and easier to separate visually, repeatability improves
Procedure The treatment is administered by a qualified professional in a clinical setting
120 For example, some senescence-associated proteins (eg, BCL-2, p53, SASP factors) are also expressed in normal, proliferating cells, leading to potential off-target effects
US$ 23.00
US$ 26.17
US$ 21.96
US$ 29.56
US$ 23.53
US$ 28.73
US$ 27.86
